Connor, Clark & Lunn Investment Management Ltd.
Position in CORT — Corcept Therapeutics Inc
CIK 1596800
VANCOUVER, A1
Position in CORT
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$7,092,424
+$2,337,699 QoQ
Shares Held
81,569
-30.8% QoQ
Ownership
0.075%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#87
of 423 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CORT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Connor, Clark & Lunn Investment Management Ltd. holds $650,455,382 across 105 Biotechnology names. CORT ranks #22 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
135,236 | $67,175,777 | |
| 2 | IONS |
Ionis Pharmaceuticals Inc
|
684,236 | $54,253,072 | |
| 3 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
625,569 | $50,990,129 | |
| 4 | MIRM |
Mirum Pharmaceuticals, Inc.
|
420,063 | $49,176,775 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
42,465 | $26,478,625 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
97,698 | $23,913,539 | |
| 7 | INSM |
INSMED Inc
|
212,676 | $22,675,515 | |
| 8 | VKTX |
Viking Therapeutics, Inc.
|
530,607 | $20,698,979 |
All Filings in CORT
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,092,424 | 81,569 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $4,754,725 | 117,954 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $7,706,251 | 221,444 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $30,739,812 | 369,869 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $23,341,567 | 318,005 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $85,804,119 | 751,218 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $40,150,500 | 796,795 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $39,780,575 | 859,563 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $23,264,659 | 716,056 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $13,657,463 | 542,178 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $11,732,003 | 361,207 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $9,876,381 | 362,436 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $8,074,703 | 362,908 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $4,787,119 | 221,012 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $2,817,870 | 138,743 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $2,110,120 | 82,298 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $1,775,509 | 74,664 | Shares | Sole | 2022-08-05 | |
| 2022-03-31 | $3,097,626 | 137,550 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $952,399 | 48,101 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $233,208 | 11,850 | Shares | Sole | 2021-11-12 | |
| No filing history on record for this holder in this stock. | ||||||